Schafer Cullen Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Schafer Cullen Capital Management's LLY Position: Q1 2021 in Review
Schafer Cullen Capital Management reduced its Eli Lilly (LLY) stake by 91% in Q1 2021, selling an estimated $76.2M and leaving 37,115 shares worth $6.93M. The position accounts for 1.41% of the portfolio, ranked #33.
Schafer Cullen Capital Management first reported a position in LLY in Q2 2013 and has held it in 32 quarters since. The position peaked at $212M in Q1 2015. 1,948 funds tracked by Wall St. Rank hold LLY as of Q1 2021.
- Schafer Cullen Capital Management held 37,115 shares of Eli Lilly worth $6.93M as of Q1 2021.
- Schafer Cullen Capital Management sold 389,737 Eli Lilly shares in Q1 2021, an estimated $76.2M.
- Eli Lilly made up 1.41% of Schafer Cullen Capital Management's portfolio in Q1 2021, its #33 holding.
- Schafer Cullen Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 32 quarters since.
- Schafer Cullen Capital Management's Eli Lilly position peaked at $212M in Q1 2015.
- 1,948 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2021.
Based on Schafer Cullen Capital Management's 13F filing for Q1 2021, filed 10 May 2021.